EDGAR Filing Documents for 0001171843-17-004105

Form 8-K - Current report:

SEC Accession No. 0001171843-17-004105

Filing Date

2017-07-17

Accepted

2017-07-17 08:01:45

Documents

Period of Report

2017-07-14

Items

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_071717.htm	8-K	29693
2	EXHIBIT 10.1	exh_101.htm	EX-10.1	240707
3	EXHIBIT 10.2	exh_102.htm	EX-10.2	17247
4	EXHIBIT 10.3	exh_103.htm	EX-10.3	82970
5	EXHIBIT 99.1	exh_991.htm	EX-99.1	7025
	Complete submission text file	0001171843-17-004105.txt		379288

Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281

Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520

Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)